From owner-chemistry@ccl.net Mon Mar 24 17:50:00 2014 From: "Diana O Rourke diana.orourke**certara.com" To: CCL Subject: CCL: Rationalize and predict patient package insert information on side effects, based on molecular structure (webinar invitation) Message-Id: <-49869-140324154107-5816-ACmfJyx2cosa2xrBDjPePw]|[server.ccl.net> X-Original-From: "Diana O'Rourke" Content-Language: en-US Content-Type: multipart/alternative; boundary="_000_BDEBE0F798A180419DDCD69746D7F8F30C0755DEFDs01itwsex01_" Date: Mon, 24 Mar 2014 14:36:19 -0500 MIME-Version: 1.0 Sent to CCL by: "Diana O'Rourke" [diana.orourke * certara.com] --_000_BDEBE0F798A180419DDCD69746D7F8F30C0755DEFDs01itwsex01_ Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Are you interested in learning how patient package insert information on si= de effects can be rationalized and predicted based on molecular structure? = How would your research change if you could predict clinical effects, espe= cially unexpected off-target ones, using molecular structural and phenotypi= c data? Join us March 27 at 11AM Eastern (New York) for the webinar: Hybrid Approac= hes for Predictive Modeling Using the Surflex Platform: Combine Docking, Li= gand- and Protein-Pocket Similarity to hear= how modeling approaches can be combined to tackle challenges such as off-t= arget prediction, improving prediction of protein-ligand interactions, and = understanding the relationship between genotype and phenotype. Our featured speaker is: Ajay N. Jain, Ph.D., internationally known expert = in computer-aided drug design; Professor, UCSF, Department of Bioengineerin= g and Therapeutic Science and Member, UCSF Helen Diller Family Comprehensiv= e Cancer Center, Program in Quantitative Biology (iPQB). LEARN MORE AND REGISTER TODAY Hope to see you online - but if you're interested in the topic and can't at= tend the live event, just register and we'll send you a link to the recordi= ng! Best regards, Diana O'Rourke Certara Marketing diana.orourke(at)certara.com=0A=0A=0ANOTICE: The information contained in t= his electronic mail message is intended only for the personal and confident= ial=20=0Ause of the designated recipient(s) named above. This message may b= e an attorney-client communication, may be protected=20=0Aby the work produ= ct doctrine, and may be subject to a protective order. As such, this messag= e is privileged and=20=0Aconfidential. If the reader of this message is not= the intended recipient or an agent responsible for delivering it to=20=0At= he intended recipient, you are hereby notified that you have received this = message in error and that any review,=20=0Adissemination, distribution, or = copying of this message is strictly prohibited. If you have received this= =20=0Acommunication in error, please notify us immediately by telephone and= e-mail and destroy any and all copies of this=20=0Amessage in your possess= ion (whether hard copies or electronically stored copies). Thank you.=0A=0A= buSp9xeMeKEbrUze --_000_BDEBE0F798A180419DDCD69746D7F8F30C0755DEFDs01itwsex01_ Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable =0A
=0A
=0A =20

Are you interested in= learning how patient package= insert information on side effects can be rationalized and predicted based= on molecular structure? How would your research change if you could predict clinical effects, especially unexpecte= d off-target ones, using molecular structural and phenotypic data?

Join us March= 27 at 11AM Eastern (New York) for the webinar:&n= bsp;<= b>Hybrid Approaches for Predictive Modeling Using the Surflex Platform: Combine Dock= ing, Ligand- and Protein-Pocket Similarity to hear how modeling approaches can be combin= ed to tackle challenges such as off-target prediction, improving prediction of protein-ligand interactions, and unders= tanding the relationship between genotype and phenotype.

Our featured speaker = is: Ajay N. Jain, Ph.D., internationally known expert in comput= er-aided drug design; Professor, UCSF, Department of Bioengineering an= d Therapeutic Science and Member, UCSF Helen Diller Family Comprehensive Cancer Center, Program in Quantitative Biology = (iPQB).

LEARN MORE AND REGISTER TODAY

Hope to see you onlin= e – but if you’re interested in the topic and can’t atten= d the live event, just register and we’ll send you a link to the reco= rding!

Best regards,

Diana O’Rourke

Certara Marketing=

diana.orourke(at)certara= .com

=0A
=0A
=0A=0A=0A<= td>NOTICE: T= he information contained in this electronic mail message is intended only f= or the personal and confidential use of the designated recipient(s) named a= bove. This message may be an attorney-client communication, may be protecte= d by the work product=20=0Adoctrine, and may be subject to a protective ord= er. As such, this message is privileged and confidential. If the reader of = this message is not the intended recipient or an agent responsible for deli= vering it to the intended recipient, you are hereby notified that you have= =20=0Areceived this message in error and that any review, dissemination, di= stribution, or copying of this message is strictly prohibited. If you have = received this communication in error, please notify us immediately by telep= hone and e-mail and destroy any and all copies of=20=0Athis message in your= possession (whether hard copies or electronically stored copies). Thank yo= u.=0A=0A=0A

=0A
=0AbuSp9xeMeKEbrUze=0A
=0A --_000_BDEBE0F798A180419DDCD69746D7F8F30C0755DEFDs01itwsex01_--